RESFLOR Solution

Maa: Kanada

Kieli: ranska

Lähde: Health Canada

Aktiivinen ainesosa:

Florfénicol; FLUNIXINE (MÉGLUMINE DE FLUNIXINE)

Saatavilla:

INTERVET CANADA CORP

Annos:

300MG; 16.5MG

Lääkemuoto:

Solution

Koostumus:

Florfénicol 300MG; FLUNIXINE (MÉGLUMINE DE FLUNIXINE) 16.5MG

Antoreitti:

Sous-cutanée

Kpl paketissa:

100ML/250ML/500ML

Prescription tyyppi:

Prescription

Terapeuttinen ryhmä:

Bétails

Tuoteyhteenveto:

Numéro de groupe d'ingrédients actifs (GIA) :0252643001

Valtuutuksen tilan:

APPROUVÉ

Valtuutus päivämäärä:

2009-07-30

Pakkausseloste

Resflor product insert English
February 14, 2023
1
DIN 02330997
Resflor
®
Florfenicol/Flunixin, as
flunixin meglumine
FOR VETERINARY USE ONLY
Injectable Solution
Sterile Multi-dose Injectable Antibiotic/Non
‑
steroidal
Anti
‑
inflammatory Solution
For Subcutaneous Use in Cattle Only
DESCRIPTION: Resflor is a sterile solution of a synthetic
broad-spectrum
antibiotic and a non
‑
steroidal anti
‑
inflammatory drug.
Each milliliter of Resflor contains: ACTIVE INGREDIENTS: 300 mg
florfenicol; 27.4
mg flunixin meglumine equivalent to 16.5 mg flunixin; NON
‑
MEDICINAL
INGREDIENTS: 250 mg _N_
‑
methyl
‑
2
‑
pyrrolidone (NMP), 10 mg citric acid and
polyethylene glycol q.s.; PRESERVATIVE: 150 mg propylene glycol.
INDICATIONS: Resflor is indicated for the treatment of bovine
respiratory
disease complex (BRD) associated with _Mannheimia haemolytica_,
_Pasteurella _
_multocida _and _Histophilus somni _and BRD associated pyrexia.
DOSAGE AND ADMINISTRATION: Resflor should be administered as a single
subcutaneous dose of 40 mg/kg florfenicol and 2.2 mg/kg flunixin (2
mL/15 kg
body weight or 6 mL/100 lbs body weight). Do not administer more than
10 mL at
each injection site.
THE INJECTION SHOULD BE GIVEN ONLY IN THE NECK. Do not puncture the
stopper
more than 20 times.
RESFLOR DOSAGE GUIDE
ANIMAL WEIGHT
(KG) (LBS)
RESFLOR DOSAGE
2 ML/15 KG BODY WEIGHT (ML)
45 100
6.0
90 200
12.0
135 300
18.0
180 400
24.0
225 500
30.0
270 600
36.0
315 700
42.0
360 800
48.0
405 900
54.0
450 1000
60.0
Resflor product insert English
February 14, 2023
2
IT IS RECOMMENDED TO TREAT ANIMALS IN THE EARLY STAGES OF THE DISEASE
AND TO
EVALUATE THE RESPONSE TO TREATMENT 72 HOURS AFTER INJECTION. IF
CLINICAL SIGNS
OF RESPIRATORY DISEASE PERSIST OR INCREASE, OR IF RELAPSE OCCURS,
TREATMENT
SHOULD BE CHANGED, USING ANOTHER ANTIBIOTIC, AND CONTINUED UNTIL SIGNS
HAVE RESOLVED.
CONTRAINDICATIONS: Do not use in animals showing hypersensitivity to
flunixin meglumine or florfenicol.
CAUTIONS: Do not exceed the recommended dose. Transient inappetence